...
首页> 外文期刊>International ophthalmology clinics >Innovative advances in aesthetic & reconstructive oculofacial plastic surgery
【24h】

Innovative advances in aesthetic & reconstructive oculofacial plastic surgery

机译:美学和重建性眼面部整形外科的创新进展

获取原文
获取原文并翻译 | 示例
           

摘要

This issue of International Ophthalmology Clinics includes many of the recent advances in oculofacial plastic and reconstructive surgery. As with many of the surgical fields, both aesthetic and reconstructive oculofacial plastic surgery has advanced significantly in the past several years by taking advantage of new technology and instrumentation, new medical therapies, and innovative approaches to the evaluation and management of conditions. In some cases, this has allowed for less-invasive surgical procedures with shorter operating times, smaller incisions, and fewer risks. Our approaches to the forehead, eyelid, lacrimal system, and orbit have continued their evolution toward minimally invasive or less-invasive interventions. New therapies or innovative uses of previously available therapies, such as the use of beta-blockers for infantile hemangiomas, have also completely revolutionized the way certain conditions are treated with significantly improved outcomes. The use of lasers, facial fillers, and botulinum toxins are other examples where conditions traditionally requiring surgical approaches are now commonly treated with office-based interventions.
机译:本期《国际眼科临床》涵盖了眼面部整形和重建手术的许多最新进展。与许多外科领域一样,在过去的几年中,利用新技术和仪器,新的药物疗法以及病情评估和管理的创新方法,美学和重建性眼面部整形手术都取得了长足的进步。在某些情况下,这允许以更少的手术时间,更小的切口和更少的风险进行侵入性较小的外科手术。我们对前额,眼睑,泪道系统和眼眶的治疗方法一直朝着微创或微创介入发展。新疗法或先前可用疗法的创新用途,例如将β受体阻滞剂用于婴儿血管瘤,也彻底改变了治疗某些病症并显着改善预后的方法。激光,面部填充剂和肉毒杆菌毒素的使用是其他实例,在这些实例中,传统上需要手术的疾病现在通常可以通过办公室干预来治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号